Amgen And The Biosimilar Threat: Lessons From Affymax
Seeking Alpha
DOJ drops Medicare fraud case against Fresenius
Mass Device
Submitted by moderatorj on Tue, 10/30/2012 - 23:17
Baxter loses bid for appeal in patent war with Fresenius
Submitted by moderatorj on Thu, 10/11/2012 - 22:57
Court overturns Fresenius' $83M Medicare fraud loss
Submitted by moderatorj on Thu, 06/28/2012 - 23:14
FDA slaps Class I recall status on Fresenius relabling
FierceMedicalDevice
Submitted by moderatorj on Tue, 11/15/2011 - 23:56